Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print June 14, 2006, doi:10.1212/01.wnl.0000231138.18629.d5)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000231138.18629.d5v1
67/3/497    most recent
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evers, S.
Right arrow Articles by Frese, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evers, S.
Right arrow Articles by Frese, A.
Related Collections
Right arrow Migraine
Right arrow All Clinical trials
Right arrow Clinical trials Observational study (Cohort, Case control)
NEUROLOGY 2006;67:497-499
© 2006 American Academy of Neurology
Brief Communications

Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen

S. Evers, MD, PhD, A. Rahmann, MD, C. Kraemer, MD, G. Kurlemann, MD, O. Debus, MD, I. W. Husstedt, MD and A. Frese, MD

From the Departments of Neurology (S.E., A.R., C.K., I.W.H., A.F.) and Neuropaediatrics (G.K., O.D.), University of Münster, Germany.

Address correspondence and reprint requests to Dr. S. Evers, Department of Neurology, University of Münster, Albert-Schweitzer-Str. 33, Germany; e-mail: everss{at}uni-muenster.de

The authors conducted a double-blind, placebo-controlled, crossover study to investigate the efficacy of oral zolmitriptan in the treatment of migraine in children and adolescents. Patients (n = 32) received placebo, zolmitriptan 2.5 mg, and ibuprofen 200 to 400 mg to treat three consecutive migraine attacks. Pain relief rates after 2 hours were 28% for placebo, 62% for zolmitriptan, and 69% for ibuprofen (p < 0.05). Both drugs are well tolerated with only mild side effects.

This article was previously published in electronic format as an Expedited E-pub on June 14, 2006, at www.neurology.org.

Disclosure: The authors report no conflicts of interest.

Received October 3, 2005.

Accepted in final form March 27, 2006.




This article has been cited by other articles:


Home page
 NeurologyHome page
D. H. Kornblau
TREATMENT OF CHILDHOOD MIGRAINE ATTACKS WITH ORAL ZOLMITRIPTAN AND IBUPROFEN
Neurology, April 24, 2007; 68(17): 1441 - 1441.
[Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
T. Tucker
A Practical Approach to Headache Treatment
Journal of Pharmacy Practice, April 1, 2007; 20(2): 123 - 136.
[Abstract] [PDF]

Home page
 Pediatr. Rev.Home page
D. W. Lewis
Pediatric Migraine
Pediatr. Rev., February 1, 2007; 28(2): 43 - 53.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen
Dina H Kornblau
Neurology Online, 31 Oct 2006 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.